These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 15937905
1. Bacterial infections in low-risk, febrile neutropenic patients. Kamana M, Escalante C, Mullen CA, Frisbee-Hume S, Rolston KV. Cancer; 2005 Jul 15; 104(2):422-6. PubMed ID: 15937905 [Abstract] [Full Text] [Related]
2. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital. Roongpoovapatr P, Suankratay C. J Med Assoc Thai; 2010 Jul 15; 93(7):776-83. PubMed ID: 20649055 [Abstract] [Full Text] [Related]
3. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group. Tamura K. Int J Antimicrob Agents; 2005 Dec 15; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072 [Abstract] [Full Text] [Related]
4. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors. Oguz A, Karadeniz C, Citak EC, Cil V, Eldes N. Pediatr Hematol Oncol; 2006 Dec 15; 23(3):245-53. PubMed ID: 16517540 [Abstract] [Full Text] [Related]
7. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia]. Jarque I, Sanz MA. Enferm Infecc Microbiol Clin; 1999 Dec 15; 17 Suppl 2():95-102. PubMed ID: 10605194 [Abstract] [Full Text] [Related]
10. Management of the febrile neutropenic patient. Picazo JJ, Association for Health Research and Development (ACINDES). Int J Antimicrob Agents; 2005 Dec 15; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492 [Abstract] [Full Text] [Related]
11. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer. Akova M, Paesmans M, Calandra T, Viscoli C, International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer. Clin Infect Dis; 2005 Jan 15; 40(2):239-45. PubMed ID: 15655741 [Abstract] [Full Text] [Related]
12. Empiric monotherapy in neutropenia: a realistic goal? Del Favero A, Bucaneve G, Menichetti F. Scand J Infect Dis Suppl; 1995 Jan 15; 96():34-7. PubMed ID: 7652501 [Abstract] [Full Text] [Related]
13. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T. Med Pediatr Oncol; 2003 Feb 15; 40(2):93-8. PubMed ID: 12461792 [Abstract] [Full Text] [Related]
16. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study. El-Mahallawy H, Sidhom I, El-Din NH, Zamzam M, El-Lamie MM. Int J Infect Dis; 2005 Jan 15; 9(1):43-51. PubMed ID: 15603994 [Abstract] [Full Text] [Related]
18. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy. Ritchie S, Palmer S, Ellis-Pegler R. Intern Med J; 2007 Jan 15; 37(1):26-31. PubMed ID: 17199841 [Abstract] [Full Text] [Related]